Breaking News Instant updates and real-time market news.

MRK

Merck

09:29
10/10/16
10/10
09:29
10/10/16
09:29

Merck trades to fresh 52-week high in pre-market

The shares were last at $64.75, edging a fresh 52-week high. At that price next resistance is at $66. Support is at $64, the prior 52-week high.

  • 25

    Oct

  • 06

    Nov

MRK Merck

10/10/16
LEER
10/10/16
NO CHANGE
LEER
Outperform
Leerink sees Bristol-Myers sliding after Merck's 'spectacular' Keytruda data
Leerink analyst Seamus Fernandez said Bristol-Myers' (BMY) Checkmate-026 data presented at the European Society of Medical Oncology meeting was disappointing, noting there was no signal of benefit on progression-free survival or overall survival and only "modest differentiation" on response rate in the 88 patients with PDL1 biomarker positivity greater than or equal to 50%. Meanwhile, Merck (MRK) presented "spectacular" data for Keytruda monotherapy at the meeting, said Fernandez, who expects Bristol shares to be down "significantly" today in light of the meeting presentations. The analyst, who still thinks Bristol has a significant opportunity to compete with Merck's Keytruda in the PDL1 high portion of the market, keeps an Outperform rating on Bristol shares, which are down nearly 6% in pre-market trading.
10/10/16
BMOC
10/10/16
NO CHANGE
BMOC
Merck should strengthen leadership in first line NSCLC, says BMO Capital
BMO Capital analyst Alex Arfaei says that upcoming data should strengthen Merck's (MRK) lead in 1L NSCLC. The analyst adds that the data could support off-label use of Merck's Keytruda in additional 1L NSCLC patients, and he says that the data "should be negative" for Bristol-Myers' (BMY) Opdivo drug. Arfaei keeps an Outperform rating on Merck and a Market Perform rating on Bristol-Myers.
10/10/16
LEER
10/10/16
NO CHANGE
LEER
Market Perform
Merck 'steals the show' at ESMO with Keytruda data, says Leerink
Leerink analyst Seamus Fernandez said Merck (MRK) stole the show at ESMO with its Keytruda data and he continues to think the company will dominate first line lung cancer treatment for years to come in patients with 50%+ PDL1 expression. Additionally, he expects Merck to gain additional traction in the overall market, noting that confirmation that Keytruda is benefiting patients when combined with Alimta/carboplatin with Alimta maintenance raises the possibility Merck could compete broadly in the overall non-squamous patient population. However, Fernandez keeps a Market Perform rating on Merck, as he thinks its current valuation largely reflects improved growth prospects through 2020.
10/10/16
JMPS
10/10/16
NO CHANGE
JMPS
Incyte treatment looking 'promising,' says JMP Securities
After reviewing recent data, JMP Securities analyst Liisa Bayko says that the combination of Incyte's (INCY) Epacadostat plus Merck's (MRK) Keytruda is "emerging as a promising treatment, potentially even best in class." The analyst says that the progression free survival rate of the combination in melanoma patients "is emerging to be quite competitive," while the efficacy rate in other solid tumors "seemed encouraging." The analyst raised her price target on Incyte to $110 from $100 and keeps an Outperform rating on the stock.

TODAY'S FREE FLY STORIES

ANY

Sphere 3D

$0.17

-0.0854 (-33.31%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Conference/Events
Sphere 3D to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

FRTA

Forterra

$7.73

0.18 (2.38%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Hot Stocks
Forterra to sell U.S. concrete, steel pressure pipe assets to Thompson Pipe »

Forterra announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

P

Pandora

$8.28

0.48 (6.15%)

, SIRI

SiriusXM

$5.35

0.11 (2.10%)

08:03
06/26/17
06/26
08:03
06/26/17
08:03
Recommendations
Pandora, SiriusXM analyst commentary  »

Pandora added to Alpha…

P

Pandora

$8.28

0.48 (6.15%)

SIRI

SiriusXM

$5.35

0.11 (2.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Jun

TROV

Trovagene

$1.14

-0.16 (-12.31%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Trovagene announces expansion of key claims for NPM1 patent portfolio »

Trovagene announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBHC

National Bank

$31.55

-0.18 (-0.57%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Conference/Events
National Bank to host conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 18

    Sep

CKPT

Checkpoint Therapeutics

$10.00

0.25 (2.56%)

, FBIO

Fortress Biotech

$4.87

0.05 (1.04%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Checkpoint Therapeutics commences trading on Nasdaq Capital Market »

Checkpoint Therapeutics…

CKPT

Checkpoint Therapeutics

$10.00

0.25 (2.56%)

FBIO

Fortress Biotech

$4.87

0.05 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

SPA

Sparton

$18.34

0.03 (0.16%)

08:02
06/26/17
06/26
08:02
06/26/17
08:02
Hot Stocks
Sparton confirms discussions with Ultra Electronics »

Sparton Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SON

Sonoco Products

$51.02

0.08 (0.16%)

08:01
06/26/17
06/26
08:01
06/26/17
08:01
Hot Stocks
Sonoco Products to acquire Clear Lam Packaging for approx. $170M in cash »

Sonoco announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jul

  • 19

    Oct

LC

LendingClub

$5.67

-0.03 (-0.53%)

08:01
06/26/17
06/26
08:01
06/26/17
08:01
Hot Stocks
LendingClub executives under investigation »

Shareholder and consumer…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSDV

pSivida

$1.91

0.09 (4.95%)

08:01
06/26/17
06/26
08:01
06/26/17
08:01
Conference/Events
pSivida to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 13

    Jul

  • 14

    Jul

  • 26

    Sep

LPCN

Lipocine

$4.21

-0.11 (-2.55%)

08:00
06/26/17
06/26
08:00
06/26/17
08:00
Hot Stocks
Lipocine announces submission of SPA on LPCN 1107 »

Lipocine announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

BAH

Booz Allen

$32.22

-0.67 (-2.04%)

08:00
06/26/17
06/26
08:00
06/26/17
08:00
Recommendations
Booz Allen analyst commentary  »

Booz Allen selloff an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Aug

  • 07

    Aug

SPGI

S&P Global

$146.70

1.32 (0.91%)

08:00
06/26/17
06/26
08:00
06/26/17
08:00
Options
S&P Global call buyer realizes 15% same-day gains »

Notable profits for the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUTR

Cutera

$24.50

-0.2 (-0.81%)

07:59
06/26/17
06/26
07:59
06/26/17
07:59
Initiation
Cutera initiated  »

Cutera initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jun

  • 30

    Jun

  • 28

    Sep

PM

Philip Morris

$119.56

-0.15 (-0.13%)

07:59
06/26/17
06/26
07:59
06/26/17
07:59
Hot Stocks
Philip Morris to invest additional EUR500M in heated tobacco facility in Italy »

Philip Morris…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GRUB

GrubHub

$47.70

1.37 (2.96%)

, AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

07:58
06/26/17
06/26
07:58
06/26/17
07:58
Downgrade
GrubHub, Amazon.com rating change  »

GrubHub downgraded to…

GRUB

GrubHub

$47.70

1.37 (2.96%)

AMZN

Amazon.com

$1,003.74

2.44 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

  • 28

    Jun

AAPL

Apple

$146.28

0.65 (0.45%)

07:57
06/26/17
06/26
07:57
06/26/17
07:57
Periodicals
Apple hires Stanford researcher for digital health, Digital Commerce 360 says »

Apple has hired Sumbul…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NBHC

National Bank

$31.55

-0.18 (-0.57%)

07:57
06/26/17
06/26
07:57
06/26/17
07:57
Hot Stocks
National Bank acquires Peoples in $143M transaction »

National Bank and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Sep

PTLA

Portola Pharmaceuticals

$56.06

17.81 (46.56%)

07:56
06/26/17
06/26
07:56
06/26/17
07:56
Recommendations
Portola Pharmaceuticals analyst commentary  »

Portola Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VOXX

VOXX

$7.85

0.25 (3.29%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Hot Stocks
Breaking Hot Stocks news story on VOXX »

VOXX trading halted, news…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NEOT

Neothetics

$2.32

0.0501 (2.21%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Hot Stocks
Breaking Hot Stocks news story on Neothetics »

Neothetics trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATHM

Autohome

$45.47

-0.15 (-0.33%)

07:55
06/26/17
06/26
07:55
06/26/17
07:55
Conference/Events
Autohome to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

NSU

Nevsun Resources

$2.27

-0.02 (-0.87%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Hot Stocks
Nevsun Resources names Ian Pearce as Board Chair, effective June 30 »

Nevsun Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MPLX

MPLX

$32.02

0.9 (2.89%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Hot Stocks
MPLX sees FY17 net income $550M-$700M, adjusted EBITDA $1.7B-$1.85B »

Sees FY net cash provided…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jun

REGN

Regeneron

$517.33

-9.2 (-1.75%)

07:52
06/26/17
06/26
07:52
06/26/17
07:52
Downgrade
Regeneron rating change  »

Regeneron downgraded on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.